These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10837791)

  • 41. Hemoglobin-based red blood cell substitutes.
    Chang TM
    Artif Organs; 2004 Sep; 28(9):789-94. PubMed ID: 15320941
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cross-linked stroma-free polyhemoglobin as a potential blood substitute.
    Keipert P; Minkowitz J; Chang TM
    Int J Artif Organs; 1982 Nov; 5(6):383-5. PubMed ID: 7160935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery.
    Yang Q; Wu W; Li Q; Chen C; Zhou R; Qiu Y; Luo M; Tan Z; Li S; Chen G; Zhou W; Liu J; Yang C; Liu J; Li T
    Oxid Med Cell Longev; 2015; 2015():125106. PubMed ID: 26161234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Oxygen Affinity of Liposome-Encapsulated Hemoglobin on Cerebral Ischemia and Reperfusion as Detected by Positron Emission Tomography in Nonhuman Primates.
    Kawaguchi AT; Yamano M; Haida M; Ohba H; Kakiuchi T; Tsukada H
    Artif Organs; 2017 Apr; 41(4):336-345. PubMed ID: 28397408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood substitutes based on modified hemoglobin prepared by encapsulation or crosslinking: an overview.
    Chang TM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):159-79. PubMed ID: 1391433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current aspects in pharmacology of modified hemoglobins.
    Palaparthy R; Wang H; Gulati A
    Adv Drug Deliv Rev; 2000 Feb; 40(3):185-98. PubMed ID: 10837789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and characterisation of poly(lactic acid) hemoglobin microspheres.
    Cedrati N; Maincent P; Thomas F; Labrude P; Vigneron C
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):867-73. PubMed ID: 7994411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thromboxane B2 in cardiac lymph. Effect of superoxide dismutase and catalase during myocardial ischemia and reperfusion.
    Michael LH; Zhang Z; Hartley CJ; Bolli R; Taylor AA; Entman ML
    Circ Res; 1990 Apr; 66(4):1040-4. PubMed ID: 2317886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "Reperfusion injury" by oxygen-derived free radicals? Effect of superoxide dismutase plus catalase, given at the time of reperfusion, on myocardial infarct size, contractile function, coronary microvasculature, and regional myocardial blood flow.
    Przyklenk K; Kloner RA
    Circ Res; 1989 Jan; 64(1):86-96. PubMed ID: 2909304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of prostaglandin I2, superoxide dismutase, and catalase on ischemia-reperfusion injury in liver transplantation.
    Tanaka J; Malchesky PS; Omokawa S; Goldcamp JB; Harasaki H; Vogt DP; Broughan TA; Nosé Y
    ASAIO Trans; 1990; 36(3):M600-3. PubMed ID: 2252762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemoglobin-based oxygen carriers: first, second or third generation? Human or bovine? Where are we now?
    Napolitano LM
    Crit Care Clin; 2009 Apr; 25(2):279-301, Table of Contents. PubMed ID: 19341909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superoxide dismutase and catalase do not improve recovery of regional myocardial contractile function when given at the time of reperfusion after reversible regional ischemia in anesthetized dogs.
    Björkman JA; Sutherland I; Gustafsson D; Sjöquist PO; Abrahamsson T
    Basic Res Cardiol; 1991; 86(3):236-44. PubMed ID: 1772387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Superoxide dismutase, catalase, and U78517F attenuate neuronal damage in gerbils with repeated brief ischemic insults.
    Truelove D; Shuaib A; Ijaz S; Richardson S; Kalra J
    Neurochem Res; 1994 Jun; 19(6):665-71. PubMed ID: 8065523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of antioxidants and PAF receptor antagonist in intestinal shock in the rat.
    Haglind E; Xia G; Rylander R
    Circ Shock; 1994 Feb; 42(2):83-91. PubMed ID: 8013065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology of hemoglobin therapeutics.
    Gulati A; Barve A; Sen AP
    J Lab Clin Med; 1999 Feb; 133(2):112-9. PubMed ID: 9989762
    [No Abstract]   [Full Text] [Related]  

  • 57. Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets.
    Armstead WM; Mirro R; Thelin OP; Shibata M; Zuckerman SL; Shanklin DR; Busija DW; Leffler CW
    Stroke; 1992 May; 23(5):755-62. PubMed ID: 1579974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lack of significant effects of superoxide dismutase and catalase on development of reperfusion arrhythmias.
    Hagar JM; Hale SL; Ilvento JP; Kloner RA
    Basic Res Cardiol; 1991; 86(2):127-35. PubMed ID: 1877967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Severity of oxygen free radical effects after ischemia and reperfusion in intestinal tissue and the influence of different drugs.
    Lutz J; Augustin A; Friedrich E
    Adv Exp Med Biol; 1990; 277():683-90. PubMed ID: 2096668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.